Received Jul 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV4 | HPV (GARDASIL) | MERCK & CO. INC. | 1 | — | — |
| HPV4 | HPV (GARDASIL) | MERCK & CO. INC. | 2 | — | — |
| HPV4 | HPV (GARDASIL) | MERCK & CO. INC. | 3 | — | — |
Neurological injury; Emotional disorder; Autoimmune Injuries; hyperactive thyroid/ Hair loss/ hot flashes/ weight loss; Brain fog/fatigue/memory loss; Emotional suffering; Pain; Grave's disease/weight loss/vision loss; Information has been received from a lawyer regarding a case in litigation concerning a 42-year-old female patient. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On unknown day (when she was 41 years old), the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (GARDASIL) suspension for injection (dose, route of administration, anatomical location, lot number, and expiry ate were not provided) as prophylaxis . Then on unknown date (when she was 42 years old), she received the second and third dose of the suspect vaccine (as described above). On unknown day, within days of the second dose of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (GARDASIL), patient began to experience hot flashes, fatigue, hair loss, and weight loss. Moreover, she had to wear protective styles and wigs for her thinning hair. Therefore, patient scheduled an appointment with her gynecologist and primary care provider to evaluate her symptoms. Providers performed blood work and the results showed she had hyperactive thyroid. Then, in June 2023, she was diagnosed with Grave's disease. Hence, the patient was treated with medication (unspecified) and saw an endocrinologist to monitor her disorder. In addition, se continued experienced daily brain fog, vision loss, hot flashes, and her weight continued to fluctuate. Patient had suffered and continues to suffer severe and permanent emotional injuries, including pain and suffering. As a direct and proximate result of her quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the patient suffered economic losses, including considerable financial expenses for medical care and treatment. The outcome of the events was considered as not recovered (as reported has suffered and continues to suffer severe and permanent physical injuries). The lawyer considered all events to be related to quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (GARDASIL). In addition, all the events were considered as disabling.
Test Name: blood work; Result Unstructured Data: hyperactive thyroid